| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Vaxcyte, Inc. | Director | Common Stock | 3,041 | $88,189 | $29.00 | 12 Jun 2025 | Direct |
| Adaptimmune Therapeutics PLC | Director | Option to purchase Ordinary Shares | 660,000 | 01 Jul 2024 | Direct | ||
| Vaxcyte, Inc. | Director | Stock Option (right to buy) | 15,372 | 12 Jun 2025 | Direct | ||
| Vaxcyte, Inc. | Director | No securities owned. | 0 | 02 Jul 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PCVX | Vaxcyte, Inc. | 12 Jun 2025 | 2 | $0 | 4 | Director | 16 Jun 2025, 18:07 |
| PCVX | Vaxcyte, Inc. | 02 Jul 2024 | 1 | $0 | 4 | Director | 03 Jul 2024, 18:12 |
| PCVX | Vaxcyte, Inc. | 02 Jul 2024 | 0 | $0 | 3 | Director | 03 Jul 2024, 18:04 |
| ADAP | Adaptimmune Therapeutics PLC | 01 Jul 2024 | 1 | $0 | 4 | Director | 01 Jul 2024, 17:02 |
| ADAP | Adaptimmune Therapeutics PLC | 03 Jul 2023 | 1 | $0 | 4 | Director | 03 Jul 2023, 17:04 |
| ADAP | Adaptimmune Therapeutics PLC | 01 Jul 2022 | 1 | $0 | 4 | Director | 01 Jul 2022, 17:02 |
| ADAP | Adaptimmune Therapeutics PLC | 01 Jul 2021 | 1 | $0 | 4 | Director | 02 Jul 2021, 17:03 |